Sang-Yong Park
Director/Board Member at GS GLOBAL CORP.
Profile
Sang-Yong Park is currently an Independent Director at GS Global Corp., a Director at Immunomic Therapeutics, Inc., and a Trustee at East Asia Institute.
He previously worked as the Chief Executive Officer at Macquarie Securities Korea Ltd.
Park received his graduate degree from The Trustees of Columbia University in The City of New York in 1992 and his undergraduate degree from the University of California in 1990.
Sang-Yong Park active positions
| Companies | Position | Start |
|---|---|---|
| GS GLOBAL CORP. | Director/Board Member | 2017-03-23 |
Immunomic Therapeutics, Inc.
 Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Director/Board Member | 2021-07-26 |
| East Asia Institute | Director/Board Member | - |
Former positions of Sang-Yong Park
| Companies | Position | End |
|---|---|---|
Macquarie Securities Korea Ltd.
 Macquarie Securities Korea Ltd. Investment Banks/BrokersFinance Macquarie Securities Korea Ltd. (MSKL) is the South Korean broker/dealer subsidiary of Great Britain-based Macquarie Internationale Investments Ltd., ultimately held by Macquarie Group Ltd. (ASX: MQG) in Australia. Headquartered in Seoul, MSKL was founded in 2006 and offers cash equities broking and risk and arbitrage trading services. | Chief Executive Officer | - |
Training of Sang-Yong Park
| University of California | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GS GLOBAL CORP. | Distribution Services |
| Private companies | 3 |
|---|---|
Macquarie Securities Korea Ltd.
Macquarie Securities Korea Ltd. Investment Banks/BrokersFinance Macquarie Securities Korea Ltd. (MSKL) is the South Korean broker/dealer subsidiary of Great Britain-based Macquarie Internationale Investments Ltd., ultimately held by Macquarie Group Ltd. (ASX: MQG) in Australia. Headquartered in Seoul, MSKL was founded in 2006 and offers cash equities broking and risk and arbitrage trading services. | Finance |
Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. BiotechnologyHealth Technology Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl, Bernard C. Rudnick and Thomas J. August and is headquartered in Rockville, MD. | Health Technology |
| East Asia Institute |
- Stock Market
- Insiders
- Sang-Yong Park